Natural human GLP-1 breaks down quickly in the body, and its effects are short-lived
No detectable cross-reactivity to Glucagon, GLP-1, GLP-2, Oxyntomodulin, GRPP, MPGF-1, MPGF-2, Insulin, C-Peptide, or Thyroglobulin
Jul 2011;6(7):820-7
These two pathways are additive
Without clear dosing and safety data, its harder to predict how your body may respond which is why its worth approaching products like this with caution
terlipressin or octreotide, to reduce splanchnic blood flow) to be given Endoscopic banding is the most definitive method of management but can be technically difficult (Fig